Drug Topics

FEBRUARY 15, 2023

Viruses are known to precipitate autoimmune diseases, but the link between COVID-19 and autoimmune conditions requires additional research.

665

665

PhRMA

FEBRUARY 16, 2023

Did you know that insurance companies use middlemen — known as pharmacy benefit managers (PBMs) — to decide what medicines people can get and what people pay out of pocket for those medicines?

Insurance 328

Insurance 328

PharmaVoice

FEBRUARY 13, 2023

Why the recently appointed president of commercial solutions sees near limitless potential to expand Klick’s footprint across the life sciences — and how generative AI is playing a role.

264

264

STAT

FEBRUARY 17, 2023

One day last fall, Kiran’s period cramps became so painful they woke her up from a nap. The 19-year-old took some ibuprofen, but found little relief. “The pain was so bad, it felt like someone was punching me,” said Kiran, who asked to be referred to by only her first name for privacy. It felt “like I was giving birth.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

FEBRUARY 16, 2023

Nearly 40 million people in the United States suffer from migraine, with the World Health Organization classifying migraine as 1 of the 10 most disabling medical illnesses.

503

503

Fierce Pharma

FEBRUARY 14, 2023

Pfizer CEO's texts with European Commission chief trigger new NYT lawsuit kdunleavy Tue, 02/14/2023 - 10:29

145

145

STAT

FEBRUARY 15, 2023

In an unexpected shift, Moderna has decided not to ask Americans to pay for its Covid-19 vaccine, a move that follows intense criticism over initial plans to charge $110 to $130 per dose after the company pivots from government contracts to commercial distribution. The vaccine maker released a brief statement that it “remains committed” to ensuring everyone in the U.S. has access to its Covid-19 shot, regardless of whether they have health insurance coverage.

Vaccines 145

Vaccines Insurance Coverage Insurance 145

Drug Topics

FEBRUARY 13, 2023

Technology can streamline—and make safer—processes like medication reconciliation.

503

503

Fierce Healthcare

FEBRUARY 11, 2023

Doximity rolls out beta version of ChatGPT tool for docs aiming to streamline administrative paperwork hlandi Sat, 02/11/2023 - 05:02

145

145

PharmaVoice

FEBRUARY 15, 2023

After a rocky year, Passage Bio’s CEO is focused on helping the rare disease specialist bounce back.

246

246

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 16, 2023

Matt Fitzgerald used to bike up and down 3,500 feet through the Santa Ana Mountains on three-hour rides just for fun. Now, nine months after being infected with SARS-CoV-2, the virus that causes Covid-19, he can’t muster walking on flat surfaces for 20 minutes without days of exhaustion. “My long Covid life remains terrifying,” he told me.

145

145

Drug Topics

FEBRUARY 17, 2023

Senators lobbed harsh criticisms at pharmacy benefit managers during a legislative hearing.

469

469

European Pharmaceutical Review

FEBRUARY 14, 2023

The COVID-19 pandemic led to an unparalleled paradigm shift in the use of and the incorporation of new technologies into our workflows. This was particularly apparent in academia and the pharmaceutical industry, where we have seen words such as Teams and Zoom becoming part of our new lexicon of language for meetings. Now we reach for these types of online meetings without a second thought, due to the clear productivity benefits they provide over real in-person meetings. 1 However, notwithstandin

144

144

PharmaVoice

FEBRUARY 13, 2023

Build social strategies into marketing plans to reach HCPs with sharply focused messaging.

246

246

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

FEBRUARY 16, 2023

Senators question why PBMs 'even exist' in heated hearing amid push for reform rking Thu, 02/16/2023 - 14:49

144

144

Drug Topics

FEBRUARY 16, 2023

Collections of oncology drugs in 13 states are being redistributed to patients in need.

469

469

STAT

FEBRUARY 16, 2023

Akin Akinc was scouring his email spam box last summer, looking for a missing message, when he stumbled across an unexpected email from a quite recognizable name: Feng Zhang. Zhang, one of the leading scientists in the groundbreaking field of genetic editing, had reached out two days prior to discuss a new company he was working on. Since helping to discover CRISPR-Cas9 — often referred to as molecular scissors that can cut into the genome and edit DNA — Zhang has founded at least

141

141

PharmaVoice

FEBRUARY 14, 2023

Dr. Rafiq Hasan has his sights on bringing lessons learned at Bayer to ophthalmology-focused Complement Therapeutics.

147

147

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

FEBRUARY 15, 2023

GSK was warned repeatedly about Zantac impurity but played down risks: Bloomberg esagonowsky Wed, 02/15/2023 - 09:02

140

140

Drug Topics

FEBRUARY 16, 2023

The founder of Mark Cuban Cost Plus Drug Company called drug pricing "insane" during a fireside chat at the Association of Accessible Medicines annual meeting.

469

469

The Guardian - Pharmaceutical Industry

FEBRUARY 13, 2023

Appetite suppressant Wegovy, popular with celebrities, seen as breakthrough treatment but not permanent remedy Weekly weight-loss jabs that are popular with celebrities will soon be made available through high street chemists in England, despite controversy over their use. Many people struggle to tackle obesity through diet and exercise alone as they often find they regain the weight that they lose.

135

135

Fierce Healthcare

FEBRUARY 17, 2023

American Telemedicine Association announced 12 telehealth innovators challenge finalists aburky Fri, 02/17/2023 - 11:45

132

132

PharmaVoice

FEBRUARY 17, 2023

Investment in rare disease research is increasing, but a new poll of PharmaVoice readers found that roadblocks remain.

130

130

Drug Topics

FEBRUARY 14, 2023

The updated vaccine schedule includes vaccinations for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.

Vaccines 469

Vaccines 469

STAT

FEBRUARY 14, 2023

A Marburg fever outbreak in Equatorial Guinea is galvanizing efforts to test drugs and vaccines for a virus that currently has none. But every day counts, warned experts who gathered virtually on Tuesday to try to chart a course for the work. The outbreak is believed to have begun in early January, but the confirmation that the Marburg virus was responsible for the growing cluster of people sick with hemorrhagic-fever-like illness was only confirmed on Monday.

Vaccines 128

Vaccines 128

Fierce Healthcare

FEBRUARY 16, 2023

Analysis: Medicare Advantage plans more likely to deny inpatient claims pminemyer Thu, 02/16/2023 - 14:16

131

131

PharmaVoice

FEBRUARY 16, 2023

Califf outlined hopes to address advisory committees, drug pricing, digital health and more.

FDA 130

FDA 130

Drug Topics

FEBRUARY 15, 2023

It’s not possible to phone it in to your job in community pharmacy.

Community Pharmacies 468

Community Pharmacies 468

The Checkup by Singlecare

FEBRUARY 13, 2023

Lots of people love the idea of taking something natural to improve their health. For example, the idea of taking a supplement that could improve their blood pressure and reduce their chances of heart attack or cardiovascular disease may be very appealing. But how effective–and safe–is this strategy? Before you decide to start taking any supplements for their alleged antihypertensive effects, it’s important to understand what those supplements can and can’t do.

Mayo Clinic 119

Mayo Clinic Labelling FDA 119

Fierce Healthcare

FEBRUARY 15, 2023

AARP leans into at-home care with Luna, providing its 38M members with in-person MSK care aburky Wed, 02/15/2023 - 17:23

128

128

PharmaVoice

FEBRUARY 16, 2023

The Israeli biotech just entered into a collaboration with Merck to develop its own checkpoint inhibitor alongside the bestselling cancer treatment.

130

130

Drug Topics

FEBRUARY 13, 2023

The list prices of 450 medications have increased 5% overall, and more price hikes are expected.

469

469

STAT

FEBRUARY 17, 2023

A recent study of medical error published in The New England Journal of Medicine reached a shocking conclusion about patient safety: Nearly a quarter century after a highly publicized Institute of Medicine report on the prevalence of patient harm sparked vows to cut the rate by half in five years , “in-hospital adverse events” remain so common that they affect roughly one in four patients.

Hospitals 116

Hospitals 116